Company Overview of Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. provides financial services in the United States. Its franchise includes capital market, sales and trading, investment banking, real estate private equity, and other businesses and ventures. The company also operates an authorized dealer to trade the United State government securities with The Federal Reserve Bank of New York. In addition, it offers services in domestic and international equities, derivatives, convertibles and structured products, stock loan, and contracts for differences, as well as research. Further, the company provides services in repo and securities lending, mortgage-backed and asset-backed securities, corporate bonds, interest rate products, age...
499 Park Avenue
2nd, 3rd & 4th floors
New York, NY 10022
Key Executives for Cantor Fitzgerald & Co.
Principal Financial Officer
Chief Operating Officer and Senior Managing Director
Chief Executive Officer of Cantor Fitzgerald Europe
Compensation as of Fiscal Year 2014.
Cantor Fitzgerald & Co. Key Developments
Cantor Fitzgerald & Co Announces New Appointments to the Healthcare Equity Research Team
Oct 13 14
Cantor Fitzgerald & Co has announced the expansion of its Healthcare Equity Research team with the appointment of Caroline Corner, who will serve as managing director, and Daniel Brims, who will serve as vice president. In the new role, Corner will focus on equity research of medical technology companies and Brims will focus on biotechnology companies. They will both report to Christina Valauri, global director of Research, and work under Mara Goldstein, who was recently promoted to head of U.S. Healthcare Research. Corner has previously served in investor relations with Solazyme Inc. Earlier, she worked at MLV & Co. as a senior research analyst, and also held senior positions at Pacific Growth Equities and Wells Fargo Securities. Prior to entering equity research, she held engineering and product development positions at Baxter Transfusion Therapies and Eli Lilly and Company. Brims recently served as a senior research analyst at Brean Capital, Llc, where he covered the biotechnology sector. Earlier, he worked at Regeneron Pharmaceuticals, where he ran a core facility to support research and development.
Cantor Fitzgerald &Co. Appoints Samir Hussein as Head of Internet and Media Investment Banking
Aug 25 14
Cantor Fitzgerald &Co. announced the appointment of Samir Hussein as Head of Internet and Media Investment Banking. Mr. Hussein will focus on extending Cantor's investment banking reach into the internet and digital media sectors. He will be based in New York and report to Charles Edelman and Jeff Lumby, Co-Heads of Investment Banking. Mr. Hussein recently served as Managing Director in the investment banking division at JMP Securities, where he focused on M&A and financing transactions for internet and digital media clients.
Cantor Fitzgerald & Co. Presents at Capital Link's Dissect ETF's Forum 2014, Oct-23-2014 09:10 AM
Aug 22 14
Cantor Fitzgerald & Co. Presents at Capital Link's Dissect ETF's Forum 2014, Oct-23-2014 09:10 AM. Venue: The Metropolitan Club, One East 60th St., New York, New York, United States. Speakers: Reggie Browne, Senior Managing Director.
Similar Private Companies By Industry
Recent Private Companies Transactions